Dr. Jeffrey Shuren, the director of the FDA’s Center for Devices and Radiological Health (CDRH), believes the level of flexibility shown by the FDA during the COVID-19 pandemic may be needed in a post-pandemic world.
Speaking in a town hall event at The Virtual Medtech Conference hosted by AdvaMed, Shuren outlined the work the FDA has put into emergency use authorizations (EUAs) during COVID-19 and emphasized the importance of remembering the pandemic’s impact once it ends.
Get the full story on our sister site, Medical Design & Outsourcing.